Find out if you qualify for one of the ORAL trials. Apply online or call 866-439-6626.

Know someone with RA? Send a link to tell them about the ORAL trials. Email a friend.

Information for Medical Professionals

Bookmark and Share

Researchers are currently conducting a series of clinical studies, called the ORAL trials, for patients with active rheumatoid arthritis (RA) at more than 350 locations across 35 countries worldwide. The ORAL trials are part of a large Phase 3 clinical trial program designed to test the effectiveness and safety of the investigational drug CP-690,550, which is an oral pill for patients with RA.

The ORAL trials are made up of six different clinical trials.

ORAL1044
ORAL1045
ORAL1046
ORAL1064
ORAL1032
ORAL1069

Eligible patients will receive study-related medical care, including visits with a rheumatologist, at no cost.

For more information about the ORAL trials, please visit www.clinicaltrials.gov. If you are interested in becoming an investigator in the ORAL trial program, please email [email protected].

If you are an investigator in the ORAL trial program, additional resources are available to you online.